Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways

Thyroid

Volumn 21, Issue 2, 2011, Pages 169-176

  Van Zeijl, Clementine J J ^a   Fliers, Eric ^a   Van Koppen, Chris J ^b   Surovtseva, Olga V ^a   De Gooyer, Marcel E ^b   Mourits, Maarten P ^a   Wiersinga, Wilmar M ^a   Miltenburg, André M M ^b   Boelen, Anita ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; HYALURONIC ACID; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; MESSENGER RNA; RECOMBINANT THYROTROPIN; THYROTROPIN RECEPTOR;

ADIPOCYTE; ARTICLE; CARBOHYDRATE SYNTHESIS; CELL DIFFERENTIATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DECOMPRESSION SURGERY; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; ORBITAL FIBROBLAST; PHASE CONTRAST MICROSCOPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SUPERNATANT;

CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC AMP; FIBROBLASTS; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; HYALURONIC ACID; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; ORBIT; RECEPTORS, THYROTROPIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; THYROTROPIN;

EID: 79953254845     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0123     Document Type: Article

References (35)

1. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738.
2. Smith RS, Smith TJ, Blieden TM, Phipps RP 1997 Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151:317-322.
3. Jacobson A, Brinck J, Briskin MJ, Spicer AP, Heldin P 2000 Expression of human hyaluronan synthases in response to external stimuli. Biochem J 348 Pt 1:29-35. (Pubitemid 30312127)
4. Mummert ME 2005 Immunologic roles of hyaluronan. Immunol Res 31:189-206.
5. Kaback LA, Smith TJ 1999 Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 84:4079-4084. (Pubitemid 30644198)
6. Smith TJ, Bahn RS, Gorman CA, Cheavens M 1991 Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J Clin Endocrinol Metab 72:1169-1171. (Pubitemid 21921823)
7. Smith TJ, Wang HS, Evans CH 1995 Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. Am J Physiol 268:C382-C388.
8. Feldon SE, O'loughlin CW, Ray DM, Landskroner-Eiger S, Seweryniak KE, Phipps RP 2006 Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol 169:1183-1193.
9. Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M 2000 Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci 41:3249-3255.
10. Sorisky A, Pardasani D, Gagnon A, Smith TJ 1996 Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab 81:3428-3431. (Pubitemid 26296229)
11. Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M2003 Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol 30:369-380.
12. Valyasevi RW, Erickson DZ, Harteneck DA, Dutton CM, Heufelder AE, Jyonouchi SC, Bahn RS 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 84:2557-2562.
13. Agretti P, De MG, De SM, Marcocci C, Vitti P, Pinchera A, Tonacchera M 2005 Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur J Endocrinol 152:777-784. (Pubitemid 40744547)
14. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716. (Pubitemid 128506520)
15. Weetman AP 2000 Graves' disease. N Engl J Med 343:1236-1248.
16. Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S, Heckmann C, Esser J, Morgenthaler NG 2006 Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91:3464-3470. (Pubitemid 44402120)
17. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF 2000 Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf ) 52:267-271. (Pubitemid 30169681)
18. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF 2003 TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf ) 58:280-287. (Pubitemid 36308115)
19. Morshed SA, Latif R, Davies TF 2009 Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150:519-529.
20. Imai Y, Ibaraki K, Odajima R, Shishiba Y 1994 Effects of dibutyryl cyclic AMP on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts in culture. Endocr J 41:645-654.
21. Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J, Steadman R, Ludgate M 2009 Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem 284:26447-26455.
22. van Zeijl CJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, Wiersinga WM, Miltenburg AM, Boelen A 2010 Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. Thyroid 20:535-544.
23. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L 1997 Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf ) 47:9-14. (Pubitemid 27313981)
24. Bahn RS, Gorman CA, Woloschak GE, David CS, Johnson PM, Johnson CM 1987 Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab 65:665-670. (Pubitemid 17157382)
25. van Koppen CJ, Zaman GJ, Timmers CM, Kelder J, Mosselman S, van de LR, Smit MJ, Hanssen RG 2008 A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor. Naunyn Schmiedebergs Arch Pharmacol 378:503-514.
26. Tomlinson JW, Durrani OM, Bujalska IJ, Gathercole LL, Tomlins PJ, Reuser TT, Rose GE, Curnow SJ, Stewart PM, Walker EA, Rauz S 2010 The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 95:398-406.
27. Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS 2002 Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 87:2352-2358. (Pubitemid 34521530)
28. Kumar S, Schiefer R, Coenen MJ, Bahn RS 2010 A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts. Thyroid 20:59-65.
29. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A 2000 Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol 279:C335-C340.
30. Arbogast B, Hopwood JJ, Dorfman A 1975 Absence of hyaluronidase in cultured human skin fibroblasts. Biochem Biophys Res Commun 67:376-382.
31. Cao HJ, Wang HS, Zhang Y, Lin HY, Phipps RP, Smith TJ 1998 Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem 273:29615-29625. (Pubitemid 28509970)
32. Kraemer PM, Tobey RA 1972 Cell-cycle dependent desquamation of heparan sulfate from the cell surface. J Cell Biol 55:713-717.
33. Matuoka K, Namba M, Mitsui Y 1987 Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction. J Cell Biol 104:1105-1115. (Pubitemid 17068681)
34. Smith TJ, Hoa N 2004 Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metab 89:5076-5080. (Pubitemid 39391451)
35. Smith TJ, Tsai CC, Shih MJ, Tsui S, Chen B, Han R, Naik V, King CS, Press C, Kamat S, Goldberg RA, Phipps RP, Douglas RS, Gianoukakis AG 2008 Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid 18:983-988.